Details of Drug-Drug Interaction
| Drug General Information (ID: DDIG3H782O) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Magnesium sulfate | Drug Info | Irinotecan | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Analgesics | Antineoplastics | |||||||
| Structure | |||||||||
| Mechanism of Magnesium sulfate-Irinotecan Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Increased risk of other adverse reactions (Unspecific) Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Magnesium sulfate | Irinotecan | |||||||
| Mechanism | Laxative | Diarrhea | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Adverse reactions | ||||||||
| Factor Description | An adverse reaction is an unexpected negative reaction to a medication or treatment that happens even when it's used correctly. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | In patients requiring laxatives for constipation associated with narcotic administration, the standard regimen may be continued under supervision of the clinician. However, patients should be advised to inform their physician of any changes in their bowel habit so that dosage adjustments or discontinuation of laxatives may be done promptly. | ||||||||
| References | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Product Information. Camptosar (irinotecan). Pharmacia and Upjohn, Kalamazoo, MI. | ||||||||||||||||||
